Biophotonics Comprehensive Study by Type (Single Photon Source, Lasers, LEDs, Lamps, Others), Application (Biotechnology, Medicine, Environmental technology, Agricultural sciences, Chemical and pharmaceutical industry, Others), Technology (See-Through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Others), End-Use (Medical Diagnostics, Medical Therapeutic, Tests & Components, Nonmedical Application) Players and Region - Global Market Outlook to 2027

Biophotonics Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 10.5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biophotonics Market?

Biophotonics is a word that encompasses biology, photons, and electronics. Biophotonics is mostly used in imaging applications and to protect biological cells' integrity. Biophotonics is being used in a variety of biomedical applications, such as diagnostics and therapies. Biophotonics has made it feasible to image, analyze, and manipulate live tissues at a molecular level in a minimally or non-invasive manner. The technique of Biophotonics is used to investigate molecular mechanisms, functions, and structures. It is used in medicine to detect, diagnose, and cure diseases by studying light-tissue interactions at the micro-, nano-, and macro-organism levels. It also aids in the emission, detection, absorption, reflection, modification, and generation of radiation from biomolecular, cells, tissues, organisms, and biomaterials. Because of advancements in biosensors and greater use in the nonmedical sector, biophotonics technology is likely to rise significantly in the future years. During the projection period, the availability of money for research and development is likely to propel growth. Due to increased awareness of the benefits of biophotonics, the influence of these factors is likely to grow dramatically.

Highlights from Biophotonics Market Study
AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
Current Market Size (2021)USD23.0 Billion
UnitValue (USD Billion)
Key Companies ProfiledThermo Fisher Scientific (United States), Affymetrix, Inc. (United States), Andor Technology Ltd. (Unite Kingdom), Becton Dickinson and Company (United States), Carl Zeiss AG (Germany), FEI Company (United States), Hamamatsu Photonics K.K. (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (United States) and Zecotek Photonics Inc. (Canada)
CAGR10.5%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Biophotonics market throughout the forecasted period.

Thermo Fisher Scientific (United States), Affymetrix, Inc. (United States), Andor Technology Ltd. (Unite Kingdom), Becton Dickinson and Company (United States), Carl Zeiss AG (Germany), FEI Company (United States), Hamamatsu Photonics K.K. (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (United States) and Zecotek Photonics Inc. (Canada) are some of the key players profiled in the study.

Biophotonics Market Segmentation:
ScopeSub-Segments
Application / End UserBiotechnology, Medicine, Environmental technology, Agricultural sciences, Chemical and pharmaceutical industry and Others
TypeSingle Photon Source, Lasers, LEDs, Lamps and Others
TechnologySee-Through Imaging,Inside Imaging,Spectro Molecular,Surface Imaging,Microscopy,Others
End-UseMedical Diagnostics,Medical Therapeutic,Tests & Components,Nonmedical Application

According to AMA, the Global Biophotonics market is expected to see steady growth rate and may see market size of USD48.0 Billion by 2027.

On the basis of application, Biotechnology segment is dominating the market in the year 2021

On the basis of geography, the market of Biophotonics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Geriatric Population
  • Increasing Use OfBiophotonics in Cell and Tissue Diagnostics

Market Trend
  • The emergence of Nanotechnology in Biophotonics

Restraints
  • Lack of Awareness of Biophotonics Technology and Skilled Personnel
  • High Cost of Technology

Opportunities
  • Development of Novel Photoacoustic Tomography (PAT) System
  • Emerging Markets in the Developing Countries

Challenges
  • Government Regulations and Long Certification & Approval Cycles


In November 2020, Jenoptik Light and Optics BioPhotonics Group won several new development orders in North America.
BioPhotonics Phototherapy Systems require 510(k) Premarket Notification. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act).

Key Target Audience
Medical Device Manufacturers, End-Users, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Single Photon Source
  • Lasers
  • LEDs
  • Lamps
  • Others
By Application
  • Biotechnology
  • Medicine
  • Environmental technology
  • Agricultural sciences
  • Chemical and pharmaceutical industry
  • Others
By Technology
  • See-Through Imaging
  • Inside Imaging
  • Spectro Molecular
  • Surface Imaging
  • Microscopy
  • Others

By End-Use
  • Medical Diagnostics
  • Medical Therapeutic
  • Tests & Components
  • Nonmedical Application

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population
      • 3.2.2. Increasing Use OfBiophotonics in Cell and Tissue Diagnostics
    • 3.3. Market Challenges
      • 3.3.1. Government Regulations and Long Certification & Approval Cycles
    • 3.4. Market Trends
      • 3.4.1. The emergence of Nanotechnology in Biophotonics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biophotonics, by Type, Application, Technology, End-Use and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biophotonics (Value)
      • 5.2.1. Global Biophotonics by: Type (Value)
        • 5.2.1.1. Single Photon Source
        • 5.2.1.2. Lasers
        • 5.2.1.3. LEDs
        • 5.2.1.4. Lamps
        • 5.2.1.5. Others
      • 5.2.2. Global Biophotonics by: Application (Value)
        • 5.2.2.1. Biotechnology
        • 5.2.2.2. Medicine
        • 5.2.2.3. Environmental technology
        • 5.2.2.4. Agricultural sciences
        • 5.2.2.5. Chemical and pharmaceutical industry
        • 5.2.2.6. Others
      • 5.2.3. Global Biophotonics by: Technology (Value)
        • 5.2.3.1. See-Through Imaging
        • 5.2.3.2. Inside Imaging
        • 5.2.3.3. Spectro Molecular
        • 5.2.3.4. Surface Imaging
        • 5.2.3.5. Microscopy
        • 5.2.3.6. Others
      • 5.2.4. Global Biophotonics by: End-Use (Value)
        • 5.2.4.1. Medical Diagnostics
        • 5.2.4.2. Medical Therapeutic
        • 5.2.4.3. Tests & Components
        • 5.2.4.4. Nonmedical Application
      • 5.2.5. Global Biophotonics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Biophotonics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Affymetrix, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Andor Technology Ltd. (Unite Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Carl Zeiss AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. FEI Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hamamatsu Photonics K.K. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Olympus Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PerkinElmer, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Zecotek Photonics Inc. (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biophotonics Sale, by Type, Application, Technology, End-Use and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biophotonics (Value)
      • 7.2.1. Global Biophotonics by: Type (Value)
        • 7.2.1.1. Single Photon Source
        • 7.2.1.2. Lasers
        • 7.2.1.3. LEDs
        • 7.2.1.4. Lamps
        • 7.2.1.5. Others
      • 7.2.2. Global Biophotonics by: Application (Value)
        • 7.2.2.1. Biotechnology
        • 7.2.2.2. Medicine
        • 7.2.2.3. Environmental technology
        • 7.2.2.4. Agricultural sciences
        • 7.2.2.5. Chemical and pharmaceutical industry
        • 7.2.2.6. Others
      • 7.2.3. Global Biophotonics by: Technology (Value)
        • 7.2.3.1. See-Through Imaging
        • 7.2.3.2. Inside Imaging
        • 7.2.3.3. Spectro Molecular
        • 7.2.3.4. Surface Imaging
        • 7.2.3.5. Microscopy
        • 7.2.3.6. Others
      • 7.2.4. Global Biophotonics by: End-Use (Value)
        • 7.2.4.1. Medical Diagnostics
        • 7.2.4.2. Medical Therapeutic
        • 7.2.4.3. Tests & Components
        • 7.2.4.4. Nonmedical Application
      • 7.2.5. Global Biophotonics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biophotonics: by Type(USD Billion)
  • Table 2. Biophotonics Single Photon Source , by Region USD Billion (2016-2021)
  • Table 3. Biophotonics Lasers , by Region USD Billion (2016-2021)
  • Table 4. Biophotonics LEDs , by Region USD Billion (2016-2021)
  • Table 5. Biophotonics Lamps , by Region USD Billion (2016-2021)
  • Table 6. Biophotonics Others , by Region USD Billion (2016-2021)
  • Table 7. Biophotonics: by Application(USD Billion)
  • Table 8. Biophotonics Biotechnology , by Region USD Billion (2016-2021)
  • Table 9. Biophotonics Medicine , by Region USD Billion (2016-2021)
  • Table 10. Biophotonics Environmental technology , by Region USD Billion (2016-2021)
  • Table 11. Biophotonics Agricultural sciences , by Region USD Billion (2016-2021)
  • Table 12. Biophotonics Chemical and pharmaceutical industry , by Region USD Billion (2016-2021)
  • Table 13. Biophotonics Others , by Region USD Billion (2016-2021)
  • Table 14. Biophotonics: by Technology(USD Billion)
  • Table 15. Biophotonics See-Through Imaging , by Region USD Billion (2016-2021)
  • Table 16. Biophotonics Inside Imaging , by Region USD Billion (2016-2021)
  • Table 17. Biophotonics Spectro Molecular , by Region USD Billion (2016-2021)
  • Table 18. Biophotonics Surface Imaging , by Region USD Billion (2016-2021)
  • Table 19. Biophotonics Microscopy , by Region USD Billion (2016-2021)
  • Table 20. Biophotonics Others , by Region USD Billion (2016-2021)
  • Table 21. Biophotonics: by End-Use(USD Billion)
  • Table 22. Biophotonics Medical Diagnostics , by Region USD Billion (2016-2021)
  • Table 23. Biophotonics Medical Therapeutic , by Region USD Billion (2016-2021)
  • Table 24. Biophotonics Tests & Components , by Region USD Billion (2016-2021)
  • Table 25. Biophotonics Nonmedical Application , by Region USD Billion (2016-2021)
  • Table 26. South America Biophotonics, by Country USD Billion (2016-2021)
  • Table 27. South America Biophotonics, by Type USD Billion (2016-2021)
  • Table 28. South America Biophotonics, by Application USD Billion (2016-2021)
  • Table 29. South America Biophotonics, by Technology USD Billion (2016-2021)
  • Table 30. South America Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 31. Brazil Biophotonics, by Type USD Billion (2016-2021)
  • Table 32. Brazil Biophotonics, by Application USD Billion (2016-2021)
  • Table 33. Brazil Biophotonics, by Technology USD Billion (2016-2021)
  • Table 34. Brazil Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 35. Argentina Biophotonics, by Type USD Billion (2016-2021)
  • Table 36. Argentina Biophotonics, by Application USD Billion (2016-2021)
  • Table 37. Argentina Biophotonics, by Technology USD Billion (2016-2021)
  • Table 38. Argentina Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 39. Rest of South America Biophotonics, by Type USD Billion (2016-2021)
  • Table 40. Rest of South America Biophotonics, by Application USD Billion (2016-2021)
  • Table 41. Rest of South America Biophotonics, by Technology USD Billion (2016-2021)
  • Table 42. Rest of South America Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 43. Asia Pacific Biophotonics, by Country USD Billion (2016-2021)
  • Table 44. Asia Pacific Biophotonics, by Type USD Billion (2016-2021)
  • Table 45. Asia Pacific Biophotonics, by Application USD Billion (2016-2021)
  • Table 46. Asia Pacific Biophotonics, by Technology USD Billion (2016-2021)
  • Table 47. Asia Pacific Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 48. China Biophotonics, by Type USD Billion (2016-2021)
  • Table 49. China Biophotonics, by Application USD Billion (2016-2021)
  • Table 50. China Biophotonics, by Technology USD Billion (2016-2021)
  • Table 51. China Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 52. Japan Biophotonics, by Type USD Billion (2016-2021)
  • Table 53. Japan Biophotonics, by Application USD Billion (2016-2021)
  • Table 54. Japan Biophotonics, by Technology USD Billion (2016-2021)
  • Table 55. Japan Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 56. India Biophotonics, by Type USD Billion (2016-2021)
  • Table 57. India Biophotonics, by Application USD Billion (2016-2021)
  • Table 58. India Biophotonics, by Technology USD Billion (2016-2021)
  • Table 59. India Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 60. South Korea Biophotonics, by Type USD Billion (2016-2021)
  • Table 61. South Korea Biophotonics, by Application USD Billion (2016-2021)
  • Table 62. South Korea Biophotonics, by Technology USD Billion (2016-2021)
  • Table 63. South Korea Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 64. Taiwan Biophotonics, by Type USD Billion (2016-2021)
  • Table 65. Taiwan Biophotonics, by Application USD Billion (2016-2021)
  • Table 66. Taiwan Biophotonics, by Technology USD Billion (2016-2021)
  • Table 67. Taiwan Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 68. Australia Biophotonics, by Type USD Billion (2016-2021)
  • Table 69. Australia Biophotonics, by Application USD Billion (2016-2021)
  • Table 70. Australia Biophotonics, by Technology USD Billion (2016-2021)
  • Table 71. Australia Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 72. Rest of Asia-Pacific Biophotonics, by Type USD Billion (2016-2021)
  • Table 73. Rest of Asia-Pacific Biophotonics, by Application USD Billion (2016-2021)
  • Table 74. Rest of Asia-Pacific Biophotonics, by Technology USD Billion (2016-2021)
  • Table 75. Rest of Asia-Pacific Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 76. Europe Biophotonics, by Country USD Billion (2016-2021)
  • Table 77. Europe Biophotonics, by Type USD Billion (2016-2021)
  • Table 78. Europe Biophotonics, by Application USD Billion (2016-2021)
  • Table 79. Europe Biophotonics, by Technology USD Billion (2016-2021)
  • Table 80. Europe Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 81. Germany Biophotonics, by Type USD Billion (2016-2021)
  • Table 82. Germany Biophotonics, by Application USD Billion (2016-2021)
  • Table 83. Germany Biophotonics, by Technology USD Billion (2016-2021)
  • Table 84. Germany Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 85. France Biophotonics, by Type USD Billion (2016-2021)
  • Table 86. France Biophotonics, by Application USD Billion (2016-2021)
  • Table 87. France Biophotonics, by Technology USD Billion (2016-2021)
  • Table 88. France Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 89. Italy Biophotonics, by Type USD Billion (2016-2021)
  • Table 90. Italy Biophotonics, by Application USD Billion (2016-2021)
  • Table 91. Italy Biophotonics, by Technology USD Billion (2016-2021)
  • Table 92. Italy Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 93. United Kingdom Biophotonics, by Type USD Billion (2016-2021)
  • Table 94. United Kingdom Biophotonics, by Application USD Billion (2016-2021)
  • Table 95. United Kingdom Biophotonics, by Technology USD Billion (2016-2021)
  • Table 96. United Kingdom Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 97. Netherlands Biophotonics, by Type USD Billion (2016-2021)
  • Table 98. Netherlands Biophotonics, by Application USD Billion (2016-2021)
  • Table 99. Netherlands Biophotonics, by Technology USD Billion (2016-2021)
  • Table 100. Netherlands Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 101. Rest of Europe Biophotonics, by Type USD Billion (2016-2021)
  • Table 102. Rest of Europe Biophotonics, by Application USD Billion (2016-2021)
  • Table 103. Rest of Europe Biophotonics, by Technology USD Billion (2016-2021)
  • Table 104. Rest of Europe Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 105. MEA Biophotonics, by Country USD Billion (2016-2021)
  • Table 106. MEA Biophotonics, by Type USD Billion (2016-2021)
  • Table 107. MEA Biophotonics, by Application USD Billion (2016-2021)
  • Table 108. MEA Biophotonics, by Technology USD Billion (2016-2021)
  • Table 109. MEA Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 110. Middle East Biophotonics, by Type USD Billion (2016-2021)
  • Table 111. Middle East Biophotonics, by Application USD Billion (2016-2021)
  • Table 112. Middle East Biophotonics, by Technology USD Billion (2016-2021)
  • Table 113. Middle East Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 114. Africa Biophotonics, by Type USD Billion (2016-2021)
  • Table 115. Africa Biophotonics, by Application USD Billion (2016-2021)
  • Table 116. Africa Biophotonics, by Technology USD Billion (2016-2021)
  • Table 117. Africa Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 118. North America Biophotonics, by Country USD Billion (2016-2021)
  • Table 119. North America Biophotonics, by Type USD Billion (2016-2021)
  • Table 120. North America Biophotonics, by Application USD Billion (2016-2021)
  • Table 121. North America Biophotonics, by Technology USD Billion (2016-2021)
  • Table 122. North America Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 123. United States Biophotonics, by Type USD Billion (2016-2021)
  • Table 124. United States Biophotonics, by Application USD Billion (2016-2021)
  • Table 125. United States Biophotonics, by Technology USD Billion (2016-2021)
  • Table 126. United States Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 127. Canada Biophotonics, by Type USD Billion (2016-2021)
  • Table 128. Canada Biophotonics, by Application USD Billion (2016-2021)
  • Table 129. Canada Biophotonics, by Technology USD Billion (2016-2021)
  • Table 130. Canada Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 131. Mexico Biophotonics, by Type USD Billion (2016-2021)
  • Table 132. Mexico Biophotonics, by Application USD Billion (2016-2021)
  • Table 133. Mexico Biophotonics, by Technology USD Billion (2016-2021)
  • Table 134. Mexico Biophotonics, by End-Use USD Billion (2016-2021)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Biophotonics: by Type(USD Billion)
  • Table 146. Biophotonics Single Photon Source , by Region USD Billion (2022-2027)
  • Table 147. Biophotonics Lasers , by Region USD Billion (2022-2027)
  • Table 148. Biophotonics LEDs , by Region USD Billion (2022-2027)
  • Table 149. Biophotonics Lamps , by Region USD Billion (2022-2027)
  • Table 150. Biophotonics Others , by Region USD Billion (2022-2027)
  • Table 151. Biophotonics: by Application(USD Billion)
  • Table 152. Biophotonics Biotechnology , by Region USD Billion (2022-2027)
  • Table 153. Biophotonics Medicine , by Region USD Billion (2022-2027)
  • Table 154. Biophotonics Environmental technology , by Region USD Billion (2022-2027)
  • Table 155. Biophotonics Agricultural sciences , by Region USD Billion (2022-2027)
  • Table 156. Biophotonics Chemical and pharmaceutical industry , by Region USD Billion (2022-2027)
  • Table 157. Biophotonics Others , by Region USD Billion (2022-2027)
  • Table 158. Biophotonics: by Technology(USD Billion)
  • Table 159. Biophotonics See-Through Imaging , by Region USD Billion (2022-2027)
  • Table 160. Biophotonics Inside Imaging , by Region USD Billion (2022-2027)
  • Table 161. Biophotonics Spectro Molecular , by Region USD Billion (2022-2027)
  • Table 162. Biophotonics Surface Imaging , by Region USD Billion (2022-2027)
  • Table 163. Biophotonics Microscopy , by Region USD Billion (2022-2027)
  • Table 164. Biophotonics Others , by Region USD Billion (2022-2027)
  • Table 165. Biophotonics: by End-Use(USD Billion)
  • Table 166. Biophotonics Medical Diagnostics , by Region USD Billion (2022-2027)
  • Table 167. Biophotonics Medical Therapeutic , by Region USD Billion (2022-2027)
  • Table 168. Biophotonics Tests & Components , by Region USD Billion (2022-2027)
  • Table 169. Biophotonics Nonmedical Application , by Region USD Billion (2022-2027)
  • Table 170. South America Biophotonics, by Country USD Billion (2022-2027)
  • Table 171. South America Biophotonics, by Type USD Billion (2022-2027)
  • Table 172. South America Biophotonics, by Application USD Billion (2022-2027)
  • Table 173. South America Biophotonics, by Technology USD Billion (2022-2027)
  • Table 174. South America Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 175. Brazil Biophotonics, by Type USD Billion (2022-2027)
  • Table 176. Brazil Biophotonics, by Application USD Billion (2022-2027)
  • Table 177. Brazil Biophotonics, by Technology USD Billion (2022-2027)
  • Table 178. Brazil Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 179. Argentina Biophotonics, by Type USD Billion (2022-2027)
  • Table 180. Argentina Biophotonics, by Application USD Billion (2022-2027)
  • Table 181. Argentina Biophotonics, by Technology USD Billion (2022-2027)
  • Table 182. Argentina Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 183. Rest of South America Biophotonics, by Type USD Billion (2022-2027)
  • Table 184. Rest of South America Biophotonics, by Application USD Billion (2022-2027)
  • Table 185. Rest of South America Biophotonics, by Technology USD Billion (2022-2027)
  • Table 186. Rest of South America Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 187. Asia Pacific Biophotonics, by Country USD Billion (2022-2027)
  • Table 188. Asia Pacific Biophotonics, by Type USD Billion (2022-2027)
  • Table 189. Asia Pacific Biophotonics, by Application USD Billion (2022-2027)
  • Table 190. Asia Pacific Biophotonics, by Technology USD Billion (2022-2027)
  • Table 191. Asia Pacific Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 192. China Biophotonics, by Type USD Billion (2022-2027)
  • Table 193. China Biophotonics, by Application USD Billion (2022-2027)
  • Table 194. China Biophotonics, by Technology USD Billion (2022-2027)
  • Table 195. China Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 196. Japan Biophotonics, by Type USD Billion (2022-2027)
  • Table 197. Japan Biophotonics, by Application USD Billion (2022-2027)
  • Table 198. Japan Biophotonics, by Technology USD Billion (2022-2027)
  • Table 199. Japan Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 200. India Biophotonics, by Type USD Billion (2022-2027)
  • Table 201. India Biophotonics, by Application USD Billion (2022-2027)
  • Table 202. India Biophotonics, by Technology USD Billion (2022-2027)
  • Table 203. India Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 204. South Korea Biophotonics, by Type USD Billion (2022-2027)
  • Table 205. South Korea Biophotonics, by Application USD Billion (2022-2027)
  • Table 206. South Korea Biophotonics, by Technology USD Billion (2022-2027)
  • Table 207. South Korea Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 208. Taiwan Biophotonics, by Type USD Billion (2022-2027)
  • Table 209. Taiwan Biophotonics, by Application USD Billion (2022-2027)
  • Table 210. Taiwan Biophotonics, by Technology USD Billion (2022-2027)
  • Table 211. Taiwan Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 212. Australia Biophotonics, by Type USD Billion (2022-2027)
  • Table 213. Australia Biophotonics, by Application USD Billion (2022-2027)
  • Table 214. Australia Biophotonics, by Technology USD Billion (2022-2027)
  • Table 215. Australia Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 216. Rest of Asia-Pacific Biophotonics, by Type USD Billion (2022-2027)
  • Table 217. Rest of Asia-Pacific Biophotonics, by Application USD Billion (2022-2027)
  • Table 218. Rest of Asia-Pacific Biophotonics, by Technology USD Billion (2022-2027)
  • Table 219. Rest of Asia-Pacific Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 220. Europe Biophotonics, by Country USD Billion (2022-2027)
  • Table 221. Europe Biophotonics, by Type USD Billion (2022-2027)
  • Table 222. Europe Biophotonics, by Application USD Billion (2022-2027)
  • Table 223. Europe Biophotonics, by Technology USD Billion (2022-2027)
  • Table 224. Europe Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 225. Germany Biophotonics, by Type USD Billion (2022-2027)
  • Table 226. Germany Biophotonics, by Application USD Billion (2022-2027)
  • Table 227. Germany Biophotonics, by Technology USD Billion (2022-2027)
  • Table 228. Germany Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 229. France Biophotonics, by Type USD Billion (2022-2027)
  • Table 230. France Biophotonics, by Application USD Billion (2022-2027)
  • Table 231. France Biophotonics, by Technology USD Billion (2022-2027)
  • Table 232. France Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 233. Italy Biophotonics, by Type USD Billion (2022-2027)
  • Table 234. Italy Biophotonics, by Application USD Billion (2022-2027)
  • Table 235. Italy Biophotonics, by Technology USD Billion (2022-2027)
  • Table 236. Italy Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 237. United Kingdom Biophotonics, by Type USD Billion (2022-2027)
  • Table 238. United Kingdom Biophotonics, by Application USD Billion (2022-2027)
  • Table 239. United Kingdom Biophotonics, by Technology USD Billion (2022-2027)
  • Table 240. United Kingdom Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 241. Netherlands Biophotonics, by Type USD Billion (2022-2027)
  • Table 242. Netherlands Biophotonics, by Application USD Billion (2022-2027)
  • Table 243. Netherlands Biophotonics, by Technology USD Billion (2022-2027)
  • Table 244. Netherlands Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 245. Rest of Europe Biophotonics, by Type USD Billion (2022-2027)
  • Table 246. Rest of Europe Biophotonics, by Application USD Billion (2022-2027)
  • Table 247. Rest of Europe Biophotonics, by Technology USD Billion (2022-2027)
  • Table 248. Rest of Europe Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 249. MEA Biophotonics, by Country USD Billion (2022-2027)
  • Table 250. MEA Biophotonics, by Type USD Billion (2022-2027)
  • Table 251. MEA Biophotonics, by Application USD Billion (2022-2027)
  • Table 252. MEA Biophotonics, by Technology USD Billion (2022-2027)
  • Table 253. MEA Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 254. Middle East Biophotonics, by Type USD Billion (2022-2027)
  • Table 255. Middle East Biophotonics, by Application USD Billion (2022-2027)
  • Table 256. Middle East Biophotonics, by Technology USD Billion (2022-2027)
  • Table 257. Middle East Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 258. Africa Biophotonics, by Type USD Billion (2022-2027)
  • Table 259. Africa Biophotonics, by Application USD Billion (2022-2027)
  • Table 260. Africa Biophotonics, by Technology USD Billion (2022-2027)
  • Table 261. Africa Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 262. North America Biophotonics, by Country USD Billion (2022-2027)
  • Table 263. North America Biophotonics, by Type USD Billion (2022-2027)
  • Table 264. North America Biophotonics, by Application USD Billion (2022-2027)
  • Table 265. North America Biophotonics, by Technology USD Billion (2022-2027)
  • Table 266. North America Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 267. United States Biophotonics, by Type USD Billion (2022-2027)
  • Table 268. United States Biophotonics, by Application USD Billion (2022-2027)
  • Table 269. United States Biophotonics, by Technology USD Billion (2022-2027)
  • Table 270. United States Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 271. Canada Biophotonics, by Type USD Billion (2022-2027)
  • Table 272. Canada Biophotonics, by Application USD Billion (2022-2027)
  • Table 273. Canada Biophotonics, by Technology USD Billion (2022-2027)
  • Table 274. Canada Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 275. Mexico Biophotonics, by Type USD Billion (2022-2027)
  • Table 276. Mexico Biophotonics, by Application USD Billion (2022-2027)
  • Table 277. Mexico Biophotonics, by Technology USD Billion (2022-2027)
  • Table 278. Mexico Biophotonics, by End-Use USD Billion (2022-2027)
  • Table 279. Research Programs/Design for This Report
  • Table 280. Key Data Information from Secondary Sources
  • Table 281. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biophotonics: by Type USD Billion (2016-2021)
  • Figure 5. Global Biophotonics: by Application USD Billion (2016-2021)
  • Figure 6. Global Biophotonics: by Technology USD Billion (2016-2021)
  • Figure 7. Global Biophotonics: by End-Use USD Billion (2016-2021)
  • Figure 8. South America Biophotonics Share (%), by Country
  • Figure 9. Asia Pacific Biophotonics Share (%), by Country
  • Figure 10. Europe Biophotonics Share (%), by Country
  • Figure 11. MEA Biophotonics Share (%), by Country
  • Figure 12. North America Biophotonics Share (%), by Country
  • Figure 13. Global Biophotonics share by Players 2021 (%)
  • Figure 14. Global Biophotonics share by Players (Top 3) 2021(%)
  • Figure 15. Global Biophotonics share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 19. Affymetrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Affymetrix, Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Andor Technology Ltd. (Unite Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Andor Technology Ltd. (Unite Kingdom) Revenue: by Geography 2021
  • Figure 23. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 25. Carl Zeiss AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Carl Zeiss AG (Germany) Revenue: by Geography 2021
  • Figure 27. FEI Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. FEI Company (United States) Revenue: by Geography 2021
  • Figure 29. Hamamatsu Photonics K.K. (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Hamamatsu Photonics K.K. (Japan) Revenue: by Geography 2021
  • Figure 31. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Olympus Corporation (Japan) Revenue: by Geography 2021
  • Figure 33. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. PerkinElmer, Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Zecotek Photonics Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Zecotek Photonics Inc. (Canada) Revenue: by Geography 2021
  • Figure 37. Global Biophotonics: by Type USD Billion (2022-2027)
  • Figure 38. Global Biophotonics: by Application USD Billion (2022-2027)
  • Figure 39. Global Biophotonics: by Technology USD Billion (2022-2027)
  • Figure 40. Global Biophotonics: by End-Use USD Billion (2022-2027)
  • Figure 41. South America Biophotonics Share (%), by Country
  • Figure 42. Asia Pacific Biophotonics Share (%), by Country
  • Figure 43. Europe Biophotonics Share (%), by Country
  • Figure 44. MEA Biophotonics Share (%), by Country
  • Figure 45. North America Biophotonics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Affymetrix, Inc. (United States)
  • Andor Technology Ltd. (Unite Kingdom)
  • Becton Dickinson and Company (United States)
  • Carl Zeiss AG (Germany)
  • FEI Company (United States)
  • Hamamatsu Photonics K.K. (Japan)
  • Olympus Corporation (Japan)
  • PerkinElmer, Inc. (United States)
  • Zecotek Photonics Inc. (Canada)
Select User Access Type

Key Highlights of Report


Jul 2022 209 Pages 78 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Geriatric Population " is seen as one of major growth factors of Biophotonics Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Biophotonics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete of companies available in our research coverage.

Know More About Global Biophotonics Report?